Surrozen Inc
SRZN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$217.14M
Close$
$10.84
62.7% downside
Current Fair Value
62.7% downsideOvervalued by 62.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $217.14 Million |
|---|---|
| Enterprise Value | $121.42 Million |
| Earnings per Share | $-32.37 |
| Beta | 0.56 |
| Outstanding Shares | 11,663,000 |
Return
| Return on Equity | 93.58% |
|---|---|
| Return on Assets | -177.00% |
| Return on Invested Capital | -41.85% |
Valuation & Multiples
| P/E Ratio | -0.71 |
|---|---|
| PEG | -2.69 |
| Price to Sales | - |
| Price to Book Ratio | -1.53 |
| Enterprise Value to Revenue | 10.55 |
| Enterprise Value to EBIT | -2.72 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | -0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-1.29
Consensus analyst estimateRevenue Estimate
$467,250
Consensus analyst estimateNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-1.10
Consensus analyst estimateRevenue Estimate
$475,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.20%▼ 88.26% |
|---|---|
| Total Invested | $4.50M▼ 98.33% |
| Investors Holding | 5▼ 66.00% |
About Surrozen Inc
2,021 employees
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Wnt signaling plays key roles in the control of development, homeostasis, and regeneration of many essential organs a...